Annual Non Current Assets
$87.10 K
+$38.20 K+78.12%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual long term assets is $87.10 thousand, with the most recent change of +$38.20 thousand (+78.12%) on September 1, 2024.
- During the last 3 years, DRUG annual non current assets has risen by +$85.50 thousand (+5343.75%).
- DRUG annual non current assets is now -14.19% below its all-time high of $101.50 thousand, reached on September 30, 2022.
Performance
DRUG Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$87.10 K
+$78.30 K+889.77%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly long term assets is $87.10 thousand, with the most recent change of +$78.30 thousand (+889.77%) on September 1, 2024.
- Over the past year, DRUG quarterly non current assets has increased by +$50.70 thousand (+139.29%).
- DRUG quarterly non current assets is now -14.19% below its all-time high of $101.50 thousand, reached on September 30, 2022.
Performance
DRUG Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
DRUG Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +78.1% | +139.3% |
3 y3 years | +5343.8% | +139.3% |
5 y5 years | +5706.7% | +139.3% |
DRUG Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -14.2% | +5343.8% | -14.2% | +5343.8% |
5 y | 5-year | -14.2% | +5706.7% | -14.2% | +5706.7% |
alltime | all time | -14.2% | +5706.7% | -14.2% | +5706.7% |
Bright Minds Biosciences Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | $4.43 M(-11.6%) | $87.10 K(+889.8%) |
Jun 2024 | - | $8800.00(-60.5%) |
Mar 2024 | - | $22.30 K(-38.7%) |
Dec 2023 | - | $36.40 K(-25.6%) |
Sep 2023 | $5.01 M(-42.6%) | $48.90 K(-23.4%) |
Jun 2023 | - | $63.80 K(-15.9%) |
Mar 2023 | - | $75.90 K(-14.7%) |
Dec 2022 | - | $89.00 K(-12.3%) |
Sep 2022 | $8.74 M | $101.50 K(+6243.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $1600.00(0.0%) |
Mar 2022 | - | $1600.00(0.0%) |
Dec 2021 | - | $1600.00(0.0%) |
Sep 2021 | $15.71 M(+2294.4%) | - |
Sep 2021 | - | $1600.00(0.0%) |
Jun 2021 | - | $1600.00(0.0%) |
Mar 2021 | - | $1600.00(0.0%) |
Dec 2020 | - | $1600.00(+6.7%) |
Sep 2020 | $656.10 K | - |
Sep 2020 | - | $1500.00 |
FAQ
- What is Bright Minds Biosciences annual long term assets?
- What is the all time high annual non current assets for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual non current assets year-on-year change?
- What is Bright Minds Biosciences quarterly long term assets?
- What is the all time high quarterly non current assets for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly non current assets year-on-year change?
What is Bright Minds Biosciences annual long term assets?
The current annual non current assets of DRUG is $87.10 K
What is the all time high annual non current assets for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual long term assets is $101.50 K
What is Bright Minds Biosciences annual non current assets year-on-year change?
Over the past year, DRUG annual long term assets has changed by +$38.20 K (+78.12%)
What is Bright Minds Biosciences quarterly long term assets?
The current quarterly non current assets of DRUG is $87.10 K
What is the all time high quarterly non current assets for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly long term assets is $101.50 K
What is Bright Minds Biosciences quarterly non current assets year-on-year change?
Over the past year, DRUG quarterly long term assets has changed by +$50.70 K (+139.29%)